Approval · Notice of Compliance 36700 · 2026
NYDA: Notice of Compliance 36700
Issued January 9, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36700
- Date
- January 9, 2026
- Company
- G. Pohl-Boskamp GmbH & Co. KGHohenlockstedt, Schleswig-Holstein, Germany
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the package labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NYDA | Not yet assigned | — |
Medicinal ingredients
- DIMETHICONE 50 PER